GB0718870D0 - Modulation of RSK - Google Patents

Modulation of RSK

Info

Publication number
GB0718870D0
GB0718870D0 GBGB0718870.9A GB0718870A GB0718870D0 GB 0718870 D0 GB0718870 D0 GB 0718870D0 GB 0718870 A GB0718870 A GB 0718870A GB 0718870 D0 GB0718870 D0 GB 0718870D0
Authority
GB
United Kingdom
Prior art keywords
rsk
modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0718870.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Dundee filed Critical University of Dundee
Priority to GBGB0718870.9A priority Critical patent/GB0718870D0/en
Publication of GB0718870D0 publication Critical patent/GB0718870D0/en
Priority to PCT/GB2008/003221 priority patent/WO2009040512A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
GBGB0718870.9A 2007-09-27 2007-09-27 Modulation of RSK Ceased GB0718870D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0718870.9A GB0718870D0 (en) 2007-09-27 2007-09-27 Modulation of RSK
PCT/GB2008/003221 WO2009040512A2 (en) 2007-09-27 2008-09-22 Modulation of rsk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0718870.9A GB0718870D0 (en) 2007-09-27 2007-09-27 Modulation of RSK

Publications (1)

Publication Number Publication Date
GB0718870D0 true GB0718870D0 (en) 2007-11-07

Family

ID=38701760

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0718870.9A Ceased GB0718870D0 (en) 2007-09-27 2007-09-27 Modulation of RSK

Country Status (2)

Country Link
GB (1) GB0718870D0 (en)
WO (1) WO2009040512A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8093043B2 (en) 2008-06-04 2012-01-10 New York University β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
US9073926B2 (en) 2009-12-07 2015-07-07 Boehringer Ingelheim International Gmbh Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
CN109071542B (en) 2016-02-19 2021-07-20 凤凰分子设计公司 Carboxamide derivatives useful as RSK inhibitors
US10980808B2 (en) 2016-07-13 2021-04-20 The Children's Medical Center Corporation Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies
WO2019213481A1 (en) * 2018-05-04 2019-11-07 The Brigham And Women's Hospital, Inc. Methods and compositions for treating inflammatory disease or disorder
KR102272653B1 (en) * 2019-10-29 2021-07-05 순천대학교 산학협력단 Kaempferol-3-O-glucosyl-6¨-O-pentadionic acid having anti-inflammatory activity and composition comprising the same for anti-inflammatory

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725761A (en) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd Agent for protecting cartilage
JP2001247594A (en) * 2000-03-03 2001-09-11 Suntory Ltd Method of producing flavonoid compound
EP1539781A4 (en) * 2002-06-12 2009-12-02 Univ Virginia Rsk inhibitors and therapeutic uses thereof
WO2005070900A1 (en) * 2004-01-22 2005-08-04 Altana Pharma Ag N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors
WO2008157230A1 (en) * 2007-06-14 2008-12-24 University Of Virginia Patent Foundation Rsk inhibitors as anti-angiogenic therapeutics

Also Published As

Publication number Publication date
WO2009040512A3 (en) 2009-12-03
WO2009040512A2 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
HUE036318T2 (en) Modified phosphatases
EP2346424A4 (en) Spinal connection assembly
EP2263259A4 (en) High aspect ratio openings
EP2265863A4 (en) Lamp assembly
GB0809360D0 (en) Calcium modulation
GB0724019D0 (en) Implant assembly
GB0904436D0 (en) Engagement arrangement
GB0815778D0 (en) Seal
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
EP2125056A4 (en) Implant assembly
EP2192916A4 (en) Modulation of synaptogenesis
GB0812998D0 (en) Seal
PL2133419T3 (en) Uses of cyanophycin beta-dipeptides
GB0813834D0 (en) Illumination assembly
GB2465659B (en) Socket assembly
HK1150666A1 (en) Modulation contrast microscope
GB0718870D0 (en) Modulation of RSK
GB0815756D0 (en) Connection Assembly
GB2460543B (en) Flange spreader
GB2461303B (en) Camshaft assembly
TWI365363B (en) Spatial lilght modulator
EP2360143A4 (en) Sulfone compound
GB0810084D0 (en) Eqne trainign aid
GB2457967B (en) Modulation scheme
GB0712087D0 (en) Modulation of inflamation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)